SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-255027
Filing Date
2023-10-12
Accepted
2023-10-12 16:20:50
Documents
3
Effectiveness Date
2023-10-12

Document Format Files

Seq Description Document Type Size
1 S-8 POS d497403ds8pos.htm S-8 POS 55243
2 EX-5.1 d497403dex51.htm EX-5.1 18880
3 EX-23.1 d497403dex231.htm EX-23.1 1506
  Complete submission text file 0001193125-23-255027.txt   77504
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Cayman, Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-271966 | Film No.: 231322942
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-271966-01 | Film No.: 231322943
SIC: 2836 Biological Products, (No Diagnostic Substances)